The Alzheimer’s Disease Neuroimaging Initiative 3: continued innovation for clinical trial improvement

INTRODUCTION: The overall goal of the Alzheimer’s Disease Neuroimaging Initiative (ADNI) is to validate biomarkers for Alzheimer’s disease (AD) clinical trials. ADNI-3, beginning August 1, 2016, is a five year renewal of the current ADNI-2 study. METHODS: ADNI-3 will follow current and additional su...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Alzheimers Dement
Huvudupphovsmän: Weiner, Michael W., Veitch, Dallas P., Aisen, Paul S., Beckett, Laurel A., Cairns, Nigel J., Green, Robert C., Harvey, Danielle, Jack, Clifford R., Jagust, William, Morris, John C., Petersen, Ronald C., Salazar, Jennifer, Saykin, Andrew J., Shaw, Leslie M, Toga, Arthur W., Trojanowski, John Q.
Materialtyp: Artigo
Språk:Inglês
Publicerad: 2016
Ämnen:
Article
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC5536850/
https://ncbi.nlm.nih.gov/pubmed/27931796
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jalz.2016.10.006
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk